Literature DB >> 15848172

Aberrant glycosylation of alpha-dystroglycan causes defective binding of laminin in the muscle of chicken muscular dystrophy.

Fumiaki Saito1, Martina Blank, Jörn Schröder, Hiroshi Manya, Teruo Shimizu, Kevin P Campbell, Tamao Endo, Makoto Mizutani, Stephan Kröger, Kiichiro Matsumura.   

Abstract

Dystroglycan is a central component of dystrophin-glycoprotein complex that links extracellular matrix and cytoskeleton in skeletal muscle. Although dystrophic chicken is well established as an animal model of human muscular dystrophy, the pathomechanism leading to muscular degeneration remains unknown. We show here that glycosylation and laminin-binding activity of alpha-dystroglycan (alpha-DG) are defective in dystrophic chicken. Extensive glycan structural analysis reveals that Galbeta1-3GalNAc and GalNAc residues are increased while Siaalpha2-3Gal structure is reduced in alpha-DG of dystrophic chicken. These results implicate aberrant glycosylation of alpha-DG in the pathogenesis of muscular degeneration in this model animal of muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848172     DOI: 10.1016/j.febslet.2005.03.033

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Characterization of WWP1 protein expression in skeletal muscle of muscular dystrophy chickens.

Authors:  Michihiro Imamura; Akinori Nakamura; Hideyuki Mannen; Shin'ichi Takeda
Journal:  J Biochem       Date:  2015-08-26       Impact factor: 3.387

2.  Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane.

Authors:  K Hnia; G Hugon; A Masmoudi; J Mercier; F Rivier; D Mornet
Journal:  Neuroscience       Date:  2006-06-02       Impact factor: 3.590

3.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

4.  The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies.

Authors:  Vandana Gupta; Genri Kawahara; Stacey R Gundry; Aye T Chen; Wayne I Lencer; Yi Zhou; Leonard I Zon; Louis M Kunkel; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-02-04       Impact factor: 6.150

5.  Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Authors:  Paul T Martin; G Diane Shelton; Peter J Dickinson; Beverly K Sturges; Rui Xu; Richard A LeCouteur; Ling T Guo; Robert A Grahn; Harriet P Lo; Kathryn N North; Richard Malik; Eva Engvall; Leslie A Lyons
Journal:  Neuromuscul Disord       Date:  2008-11-05       Impact factor: 4.296

6.  Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.

Authors:  Kristy Swiderski; Scott A Shaffer; Byron Gallis; Guy L Odom; Andrea L Arnett; J Scott Edgar; Dale M Baum; Annabel Chee; Timur Naim; Paul Gregorevic; Kate T Murphy; James Moody; David R Goodlett; Gordon S Lynch; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2014-07-31       Impact factor: 6.150

7.  G-protein coupled receptor 56 promotes myoblast fusion through serum response factor- and nuclear factor of activated T-cell-mediated signalling but is not essential for muscle development in vivo.

Authors:  Melissa P Wu; Jamie R Doyle; Brenda Barry; Ariane Beauvais; Anete Rozkalne; Xianhua Piao; Michael W Lawlor; Alan S Kopin; Christopher A Walsh; Emanuela Gussoni
Journal:  FEBS J       Date:  2013-10-08       Impact factor: 5.542

8.  Virus entry. Lassa virus entry requires a trigger-induced receptor switch.

Authors:  Lucas T Jae; Matthijs Raaben; Andrew S Herbert; Ana I Kuehne; Ariel S Wirchnianski; Timothy K Soh; Sarah H Stubbs; Hans Janssen; Markus Damme; Paul Saftig; Sean P Whelan; John M Dye; Thijn R Brummelkamp
Journal:  Science       Date:  2014-06-27       Impact factor: 47.728

9.  Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic.

Authors:  Thais Canassa-DeLeo; Vanessa Leiria Campo; Lílian Cataldi Rodrigues; Marcelo Fiori Marchiori; Carlos Fuzo; Marcelo Macedo Brigido; Annamaria Sandomenico; Menotti Ruvo; Andrea Queiroz Maranhão; Marcelo Dias-Baruffi
Journal:  Glycoconj J       Date:  2019-12-10       Impact factor: 2.916

10.  Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.

Authors:  Josef Voglmeir; Sara Kaloo; Nicolas Laurent; Marco M Meloni; Lisa Bohlmann; Iain B H Wilson; Sabine L Flitsch
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.